Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021993
Filing Date
2025-11-12
Accepted
2025-11-12 17:00:50
Documents
50
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 817908
2 EX-31.1 ex31-1.htm EX-31.1 15819
3 EX-31.2 ex31-2.htm EX-31.2 15849
4 EX-32.1 ex32-1.htm EX-32.1 8372
  Complete submission text file 0001493152-25-021993.txt   4395435

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20250930.xsd EX-101.SCH 28593
6 XBRL CALCULATION FILE brtx-20250930_cal.xml EX-101.CAL 40447
7 XBRL DEFINITION FILE brtx-20250930_def.xml EX-101.DEF 156501
8 XBRL LABEL FILE brtx-20250930_lab.xml EX-101.LAB 273414
9 XBRL PRESENTATION FILE brtx-20250930_pre.xml EX-101.PRE 236413
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 639283
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 251474001
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)